| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| aTYR PHARMA INC | Director | Stock Option (right to buy) | 24K | May 22, 2024 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | Jun 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| JSPR | Jasper Therapeutics, Inc. | Jun 18, 2024 | 0 | $0 | 3 | Jun 20, 2024 | Director |
| LIFE | aTYR PHARMA INC | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| LIFE | aTYR PHARMA INC | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| LIFE | aTYR PHARMA INC | Apr 26, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| LIFE | aTYR PHARMA INC | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Director |